Zurcher Kantonalbank (Zurich Cantonalbank) - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$296,401
-64.3%
18,353
-8.4%
0.00%
-75.0%
Q2 2023$831,328
-30.8%
20,032
+0.2%
0.00%
-33.3%
Q1 2023$1,201,778
+0.2%
19,983
+22.2%
0.01%0.0%
Q4 2022$1,199,713
-3.5%
16,356
-0.1%
0.01%
-14.3%
Q3 2022$1,243,000
-69.9%
16,366
-72.5%
0.01%
-70.8%
Q2 2022$4,130,000
-35.1%
59,419
-22.7%
0.02%
-22.6%
Q1 2022$6,368,000
+148.8%
76,867
+125.4%
0.03%
+158.3%
Q4 2021$2,560,000
-27.8%
34,097
+11.8%
0.01%
-36.8%
Q3 2021$3,544,000
-36.7%
30,505
+20.8%
0.02%
-38.7%
Q2 2021$5,602,000
+110.8%
25,256
+25.6%
0.03%
+93.8%
Q1 2021$2,658,000
+6.7%
20,110
+39.7%
0.02%
+6.7%
Q4 2020$2,491,000
+123.4%
14,396
+43.7%
0.02%
+87.5%
Q3 2020$1,115,000
+99.1%
10,016
+6.1%
0.01%
+60.0%
Q2 2020$560,000
+28.7%
9,442
+46.1%
0.01%
+25.0%
Q1 2020$435,000
-2.5%
6,462
+22.2%
0.00%
+33.3%
Q4 2019$446,000
+23.9%
5,287
+9.8%
0.00%0.0%
Q3 2019$360,000
+24.6%
4,813
+5.2%
0.00%
+50.0%
Q2 2019$289,000
+49.0%
4,573
+13.6%
0.00%0.0%
Q1 2019$194,000
+50.4%
4,027
+4.9%
0.00%
+100.0%
Q4 2018$129,000
-35.8%
3,8390.0%0.00%
-50.0%
Q3 2018$201,000
+67.5%
3,8390.0%0.00%
+100.0%
Q2 2018$120,000
+96.7%
3,839
+37.2%
0.00%0.0%
Q1 2018$61,000
+7.0%
2,7990.0%0.00%0.0%
Q4 2017$57,000
+280.0%
2,799
+276.2%
0.00%
Q3 2017$15,0007440.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders